Maria Alejandra Clavijo-Salomon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria Alejandra Clavijo-Salomon has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Giorgio Trinchieri
Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
2 shared publications - José Alexandre Marzagão Barbuto
Laboratory of Tumor Immunology, Department of Immunology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil
2 shared publications - Adhemar Longatto-Filho
Medical Laboratory of Medical Investigation (LIM/14), Department of Pathology São Paulo University Faculty of Medicine São Paulo Brazil
1 shared publication Amiran Dzutsev
Laboratory of Integrative Cancer Immunology, Center for Cancer Research, and
1 shared publicationAna Cristina Moura Gualberto
Laboratory of Immunology of Infectious and Parasitic Diseases and Obesity, Department of Parasitology, Microbiology, and Immunology, Federal University of Juiz de Fora, Juiz de Fora, Brazil
1 shared publicationAna Marta Souza
Department of Gynecologic Clinic, School of Medicine, Universidade de São Paulo; Clinics Hospital at the São Paulo University, R. Dr. Enéas de Carvalho aguiar, 255, 5th floor, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 2 April 2025
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 13 (4) , e011281
Unlocking the power of the microbiome for successful cancer immunotherapy
In recent years, evidence has shown that the gut microbiome significantly influences responses to immunotherapy. This has sparked interest in targeting it to improve therapy outcomes and predictions of response and toxicity. Research has demonstrated that dysbiosis, often resulting from antibiotic use, can diminish the effectiveness of immune checkpoint inhibitors, and this lack of efficacy could be linked to systemic inflammation. Certain bacterial species have been identified as having beneficial and harmful effects on immunotherapy in the clinic. While a clear consensus has yet to emerge on the optimal species for therapeutic use, introducing a new microbiome into immunotherapy-refractory patients may boost their chances of responding to further treatment attempts. State-of-the-art interventions targeting the microbiome—such as fecal microbiota transplantation—are being assessed clinically for their safety and potential to enhance treatment outcomes, with promising results. Additionally, the microbiome has been leveraged for its power to predict clinical outcomes using machine learning, and surprisingly, its predictive capability is comparable to that of other described multi-biomarker clinical scores. Here, we discuss developing knowledge concerning the microbiome’s significance in cancer immunotherapy and outline future strategies for maximizing its potential in immuno-oncology.
- 2 April 2025
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 13 (4) , e011281
Open AccessUnlocking the power of the microbiome for successful cancer immunotherapy
In recent years, evidence has shown that the gut microbiome significantly influences responses to immunotherapy. This has sparked interest in targeting it to improve therapy outcomes and predictions of response and toxicity. Research has demonstrated that dysbiosis, often resulting from antibiotic use, can diminish the effectiveness of immune checkpoint inhibitors, and this lack of efficacy could be linked to systemic inflammation. Certain bacterial species have been identified as having beneficial and harmful effects on immunotherapy in the clinic. While a clear consensus has yet to emerge on the optimal species for therapeutic use, introducing a new microbiome into immunotherapy-refractory patients may boost their chances of responding to further treatment attempts. State-of-the-art interventions targeting the microbiome—such as fecal microbiota transplantation—are being assessed clinically for their safety and potential to enhance treatment outcomes, with promising results. Additionally, the microbiome has been leveraged for its power to predict clinical outcomes using machine learning, and surprisingly, its predictive capability is comparable to that of other described multi-biomarker clinical scores. Here, we discuss developing knowledge concerning the microbiome’s significance in cancer immunotherapy and outline future strategies for maximizing its potential in immuno-oncology.
- Open Access
- 4 November 2024
- Published by Springer Nature in npj Precision Oncology
- Vol. 8 (1) , 1-7
Complete response to fifth-line anti-PD-1 rechallenge in fumarate hydratase-mutated papillary renal cell carcinoma
Fumarate hydratase (FH) mutated papillary renal cell carcinoma is an aggressive variant of kidney cancer that poorly responds to conventional targeted therapies and immunotherapy. Here, we present the 10-year follow-up of a heavily pre-treated patient with several lines of therapy, achieving a remarkable complete response to anti-PD-1 rechallenge. In addition, we highlight a common immune-related adverse event of anti-PD-1, eosinophilia, as a possible biomarker of response and using TCGA data analysis, provide proof-of-concept for tumor expression of the eosinophil-related gene SIGLEC8, as a promising powerful predictor of prognosis for papillary renal cell carcinoma patients.
- 4 November 2024
- Published by Springer Nature in npj Precision Oncology
- Vol. 8 (1) , 1-7
Open AccessComplete response to fifth-line anti-PD-1 rechallenge in fumarate hydratase-mutated papillary renal cell carcinoma
Fumarate hydratase (FH) mutated papillary renal cell carcinoma is an aggressive variant of kidney cancer that poorly responds to conventional targeted therapies and immunotherapy. Here, we present the 10-year follow-up of a heavily pre-treated patient with several lines of therapy, achieving a remarkable complete response to anti-PD-1 rechallenge. In addition, we highlight a common immune-related adverse event of anti-PD-1, eosinophilia, as a possible biomarker of response and using TCGA data analysis, provide proof-of-concept for tumor expression of the eosinophil-related gene SIGLEC8, as a promising powerful predictor of prognosis for papillary renal cell carcinoma patients.
- Open Access
Clinical Applications and Immunological Aspects of Electroporation-Based Therapies
Reversible electropermeabilization (RE) is an ultrastructural phenomenon that transiently increases the permeability of the cell membrane upon application of electrical pulses. The technique was described in 1972 by Neumann and Rosenheck and is currently used in a variety of applications, from medicine to food processing. In oncology, RE is applied for the intracellular transport of chemotherapeutic drugs as well as the delivery of genetic material in gene therapies and vaccinations. This review summarizes the physical changes of the membrane, the particularities of bleomycin, and the immunological aspects involved in electrochemotherapy and gene electrotransfer, two important EP-based cancer therapies in human and veterinary oncology.
Open AccessClinical Applications and Immunological Aspects of Electroporation-Based Therapies
Reversible electropermeabilization (RE) is an ultrastructural phenomenon that transiently increases the permeability of the cell membrane upon application of electrical pulses. The technique was described in 1972 by Neumann and Rosenheck and is currently used in a variety of applications, from medicine to food processing. In oncology, RE is applied for the intracellular transport of chemotherapeutic drugs as well as the delivery of genetic material in gene therapies and vaccinations. This review summarizes the physical changes of the membrane, the particularities of bleomycin, and the immunological aspects involved in electrochemotherapy and gene electrotransfer, two important EP-based cancer therapies in human and veterinary oncology.
- Open Access
- 25 August 2020
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (16) , 3990-4006
Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation
Adaptive immune responses are acknowledged to evolve from innate immunity. However, limited information exists regarding whether encounters between innate cells direct the generation of specialized T-cell subsets. We aim to understand how natural killer (NK) cells modulate cell-mediated immunity in humans. We found that human CD14+CD16− monocytes that differentiate into inflammatory dendritic cells (DCs) are shaped at the early stages of differentiation by cell-to-cell interactions with NK cells. Although a fraction of monocytes is eliminated by NK-cell–mediated cytotoxicity, the polarization of interferon-γ (IFN-γ) at the NKp30-stabilized synapses triggers a stable IFN-γ signature in surviving monocytes that persists after their differentiation into DCs. Notably, NK-cell–instructed DCs drive the priming of type 17 CD8+ T cells (Tc17) with the capacity to produce IFN-γ and interleukin-17A. Compared with healthy donors, this cellular network is impaired in patients with classical NK-cell deficiency driven by mutations in the GATA2 gene. Our findings reveal a previously unrecognized connection by which Tc17-mediated immunity might be regulated by NK-cell–mediated tuning of antigen-presenting cells.
- 25 August 2020
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (16) , 3990-4006
Open AccessHuman NK cells prime inflammatory DC precursors to induce Tc17 differentiation
Adaptive immune responses are acknowledged to evolve from innate immunity. However, limited information exists regarding whether encounters between innate cells direct the generation of specialized T-cell subsets. We aim to understand how natural killer (NK) cells modulate cell-mediated immunity in humans. We found that human CD14+CD16− monocytes that differentiate into inflammatory dendritic cells (DCs) are shaped at the early stages of differentiation by cell-to-cell interactions with NK cells. Although a fraction of monocytes is eliminated by NK-cell–mediated cytotoxicity, the polarization of interferon-γ (IFN-γ) at the NKp30-stabilized synapses triggers a stable IFN-γ signature in surviving monocytes that persists after their differentiation into DCs. Notably, NK-cell–instructed DCs drive the priming of type 17 CD8+ T cells (Tc17) with the capacity to produce IFN-γ and interleukin-17A. Compared with healthy donors, this cellular network is impaired in patients with classical NK-cell deficiency driven by mutations in the GATA2 gene. Our findings reveal a previously unrecognized connection by which Tc17-mediated immunity might be regulated by NK-cell–mediated tuning of antigen-presenting cells.
- Open Access
- 20 September 2019
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 9, 685
4T1 Mammary Carcinoma Colonization of Metastatic Niches Is Accelerated by Obesity
Breast cancer (BC) remains the leading cause of cancer-related deaths among women, and the chances to develop it are duplicated by obesity. Still, the impact of obesity during BC progression remains less understood. We investigated the role of obesity in tumor progression using the murine model of 4T1 mammary carcinoma in BALB/c female mice, previously high-fat-diet (HFD) fed. HFD induced obesity, metabolic impairment, and high serum and fat leptin levels. After injection of 4T1-cells, HFD-mice accelerated tumor progression and metastasis. 4T1-cells found within HFD-mice metastatic niches presented higher clonogenic potential. 4T1-cells treated in vitro with fat-conditioned medium derived from HFD-mice, increased migration capacity through CXCL12 and CCL25 gradients. In HFD-mice, the infiltration and activation of immune cells into tumor-sentinel lymph nodes was overall reduced, except for activated CD4+ T cells expressing low CD25 levels. Within the bone marrow, the levels of haematopoiesis-related IL-6 and TNF-α decreased after 4T1-cells injection in HFD-mice whereas increased in the controls, suggesting that upregulation of both cytokines, regardless of the tumor, is disrupted by obesity. Finally, the expression of genes for leptin, CXCR4, and CCR9 (receptors of CXCL12 and CCL25, respectively) was negatively correlated with the infiltration of CD8 T cells in human triple-negative BC tumors from obese patients compared to non-obese. Together, our data present early evidence of systemic networks triggered by obesity that promote BC progression to the metastatic niches. Targeting these pathways might be useful to prevent the rapid BC progression observed among obese patients.
- 20 September 2019
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 9, 685
Open Access4T1 Mammary Carcinoma Colonization of Metastatic Niches Is Accelerated by Obesity
Breast cancer (BC) remains the leading cause of cancer-related deaths among women, and the chances to develop it are duplicated by obesity. Still, the impact of obesity during BC progression remains less understood. We investigated the role of obesity in tumor progression using the murine model of 4T1 mammary carcinoma in BALB/c female mice, previously high-fat-diet (HFD) fed. HFD induced obesity, metabolic impairment, and high serum and fat leptin levels. After injection of 4T1-cells, HFD-mice accelerated tumor progression and metastasis. 4T1-cells found within HFD-mice metastatic niches presented higher clonogenic potential. 4T1-cells treated in vitro with fat-conditioned medium derived from HFD-mice, increased migration capacity through CXCL12 and CCL25 gradients. In HFD-mice, the infiltration and activation of immune cells into tumor-sentinel lymph nodes was overall reduced, except for activated CD4+ T cells expressing low CD25 levels. Within the bone marrow, the levels of haematopoiesis-related IL-6 and TNF-α decreased after 4T1-cells injection in HFD-mice whereas increased in the controls, suggesting that upregulation of both cytokines, regardless of the tumor, is disrupted by obesity. Finally, the expression of genes for leptin, CXCR4, and CCR9 (receptors of CXCL12 and CCL25, respectively) was negatively correlated with the infiltration of CD8 T cells in human triple-negative BC tumors from obese patients compared to non-obese. Together, our data present early evidence of systemic networks triggered by obesity that promote BC progression to the metastatic niches. Targeting these pathways might be useful to prevent the rapid BC progression observed among obese patients.
- Open Access
- 21 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-16
Local and systemic immunomodulatory mechanisms triggered by Human Papillomavirus transformed cells: a potential role for G-CSF and neutrophils
Cervical cancer is the last stage of a series of molecular and cellular alterations initiated with Human Papillomavirus (HPV) infection. The process involves immune responses and evasion mechanisms, which culminates with tolerance toward tumor antigens. Our objective was to understand local and systemic changes in the interactions between HPV associated cervical lesions and the immune system as lesions progress to cancer. Locally, we observed higher cervical leukocyte infiltrate, reflected by the increase in the frequency of T lymphocytes, neutrophils and M2 macrophages, in cancer patients. We observed a strong negative correlation between the frequency of neutrophils and T cells in precursor and cancer samples, but not cervicitis. In 3D tumor cell cultures, neutrophils inhibited T cell activity, displayed longer viability and longer CD16 expression half-life than neat neutrophil cultures. Systemically, we observed higher plasma G-CSF concentration, higher frequency of immature low density neutrophils, and tolerogenic monocyte derived dendritic cells, MoDCs, also in cancer patients. Interestingly, there was a negative correlation between T cell activation by MoDCs and G-CSF concentration in the plasma. Our results indicate that neutrophils and G-CSF may be part of the immune escape mechanisms triggered by cervical cancer cells, locally and systemically, respectively.
- 21 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-16
Open AccessLocal and systemic immunomodulatory mechanisms triggered by Human Papillomavirus transformed cells: a potential role for G-CSF and neutrophils
Cervical cancer is the last stage of a series of molecular and cellular alterations initiated with Human Papillomavirus (HPV) infection. The process involves immune responses and evasion mechanisms, which culminates with tolerance toward tumor antigens. Our objective was to understand local and systemic changes in the interactions between HPV associated cervical lesions and the immune system as lesions progress to cancer. Locally, we observed higher cervical leukocyte infiltrate, reflected by the increase in the frequency of T lymphocytes, neutrophils and M2 macrophages, in cancer patients. We observed a strong negative correlation between the frequency of neutrophils and T cells in precursor and cancer samples, but not cervicitis. In 3D tumor cell cultures, neutrophils inhibited T cell activity, displayed longer viability and longer CD16 expression half-life than neat neutrophil cultures. Systemically, we observed higher plasma G-CSF concentration, higher frequency of immature low density neutrophils, and tolerogenic monocyte derived dendritic cells, MoDCs, also in cancer patients. Interestingly, there was a negative correlation between T cell activation by MoDCs and G-CSF concentration in the plasma. Our results indicate that neutrophils and G-CSF may be part of the immune escape mechanisms triggered by cervical cancer cells, locally and systemically, respectively.
- Open Access
- 23 March 2017
- Published by Juniper Publishers in Juniper Online Journal of Immuno Virology
- Vol. 1 (4)
Overcoming the Tumor Microenvironment with STING Agonism: Lessons Learned from Viruses
- 23 March 2017
- Published by Juniper Publishers in Juniper Online Journal of Immuno Virology
- Vol. 1 (4)
Open AccessOvercoming the Tumor Microenvironment with STING Agonism: Lessons Learned from Viruses
- Open Access
- 1 January 2015
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 6
Early contact-dependent interactions between natural killer cells and monocytes influence monocyte-derived dendritic cell function: implications for T cell polarization.
Natural killer (NK) cells play different and important roles in the immune system: surveillance, tolerance, cytotoxicity and regulation. Their capacity to be rapidly recruited into sites of inflammation and to produce high amounts of cytokines contributes to shape and magnify the adaptive immunity. Thus, in early stages of an immune response, circulating NK cells and monocytes (Mo) are recruited from blood to the tissues; however, the events that take place during and after their encounter and the impact that these events have for human immunity are not yet quite understood. The goal of this work was to study the role that NK cells play on monocytes and on their subsequent differentiation into dendritic cells (Mo-DCs). NK cells and monocytes were obtained from healthy donors’ blood and purified by separation with magnetic beads. Resting and pre-activated NK cells were co-cultured with monocytes that were then induced to differentiate into dendritic cells with IL-4 and GM-CSF for 5 days and subsequently, induced to maturate with TNF-alpha for 2 additional days. Mo-DCs’ function was tested by their co-culture with purified allogeneic naïve T cells for 5 days. Cell-cell interaction was analyzed by confocal microscopy and phenotype and function of cells were analyzed by flow cytometry. NK cells effect on Mo-DCs’ function was noticed only when NK cells were added since day 0 of the differentiation process. Day-0-NK-Mo-DCs’ capacity to stimulate T cell proliferation and IFN-gamma production increased statistically significantly when compared to monocytes alone or Day-5-NK-Mo-DCs and Day-7-NK-Mo-DCs. Intracellular cytokine analysis revealed that Day-0-NK-Mo-DCs were better stimulators of IFN-gamma production by CD8 T cells and suggested a role for the NKp30 receptor and its ligand in monocytes. Transwell experiments confirmed the importance of cell-cell contact during the differentiation process. Live imaging confocal microscopy showed that long interactions took place between NK cells and monocytes at early stages of the differentiation process, suggesting the formation of a synapse in which the NKp30 receptor might be involved. Early contact-dependent interactions between NK cells and monocytes instruct monocyte-derived dendritic cells to specialize in priming IFN-gamma production by CD8 T cells. This interaction may have implications in immunity against pathogen-infected cells and cancer cells and might be exploited for immunotherapy in which IFN-gamma production by CD8 T cell is required or exacerbated.
- 1 January 2015
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 6
Open AccessEarly contact-dependent interactions between natural killer cells and monocytes influence monocyte-derived dendritic cell function: implications for T cell polarization.
Natural killer (NK) cells play different and important roles in the immune system: surveillance, tolerance, cytotoxicity and regulation. Their capacity to be rapidly recruited into sites of inflammation and to produce high amounts of cytokines contributes to shape and magnify the adaptive immunity. Thus, in early stages of an immune response, circulating NK cells and monocytes (Mo) are recruited from blood to the tissues; however, the events that take place during and after their encounter and the impact that these events have for human immunity are not yet quite understood. The goal of this work was to study the role that NK cells play on monocytes and on their subsequent differentiation into dendritic cells (Mo-DCs). NK cells and monocytes were obtained from healthy donors’ blood and purified by separation with magnetic beads. Resting and pre-activated NK cells were co-cultured with monocytes that were then induced to differentiate into dendritic cells with IL-4 and GM-CSF for 5 days and subsequently, induced to maturate with TNF-alpha for 2 additional days. Mo-DCs’ function was tested by their co-culture with purified allogeneic naïve T cells for 5 days. Cell-cell interaction was analyzed by confocal microscopy and phenotype and function of cells were analyzed by flow cytometry. NK cells effect on Mo-DCs’ function was noticed only when NK cells were added since day 0 of the differentiation process. Day-0-NK-Mo-DCs’ capacity to stimulate T cell proliferation and IFN-gamma production increased statistically significantly when compared to monocytes alone or Day-5-NK-Mo-DCs and Day-7-NK-Mo-DCs. Intracellular cytokine analysis revealed that Day-0-NK-Mo-DCs were better stimulators of IFN-gamma production by CD8 T cells and suggested a role for the NKp30 receptor and its ligand in monocytes. Transwell experiments confirmed the importance of cell-cell contact during the differentiation process. Live imaging confocal microscopy showed that long interactions took place between NK cells and monocytes at early stages of the differentiation process, suggesting the formation of a synapse in which the NKp30 receptor might be involved. Early contact-dependent interactions between NK cells and monocytes instruct monocyte-derived dendritic cells to specialize in priming IFN-gamma production by CD8 T cells. This interaction may have implications in immunity against pathogen-infected cells and cancer cells and might be exploited for immunotherapy in which IFN-gamma production by CD8 T cell is required or exacerbated.